ArticleFrontiers in oncology2020

Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of

Maria Luisa Belli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.